pellicle
Professional Dingbat, Guru and Merkintologist
Ok ... lets try sections then:
I've had time to have a flick through this list and as I expected I didn't find anything which is beyond exactly what I said at the beginning:
"There is at best a weak link of association in some cases"
yes, there probably is ...
research funding
a pharmaceutical company who makes a much bigger profit from that drug than warfarin
there is edge cases who will benefit (and we can charge more)
interestingly Noct is vocal about how Big Pharma charges too much and twists evidence when its about the drugs he's interested in.
but this is a statement of research, not an out come so sorry, this is not evidence.
again, a statement of research ... it will be interesting to see what they uncover.
I've had time to have a flick through this list and as I expected I didn't find anything which is beyond exactly what I said at the beginning:
"There is at best a weak link of association in some cases"
I'm not really interested in going around and around with Pellicle on this one again. There will always be a hair to split, a minor phrasing to attach major importance to. Run a Google search on "Warfarin calcium progression" or "Warfarin CAC progression" or some such. You'll find a lot to read on the matter.
I do know that the "Los Angeles Biomedical Research Institute" is trying to see if Rivaroxiban pushes the progression of vascular calcification less than Warfarin. There's probably a reason that they are looking into it:
https://clinicaltrials.gov/ct2/show/NCT02376010
yes, there probably is ...
research funding
a pharmaceutical company who makes a much bigger profit from that drug than warfarin
there is edge cases who will benefit (and we can charge more)
interestingly Noct is vocal about how Big Pharma charges too much and twists evidence when its about the drugs he's interested in.
but this is a statement of research, not an out come so sorry, this is not evidence.
Well well. Here's another one looking at Apixaban vs Warfarin for the same thing. That is a different drug, right?
https://clinicaltrials.gov/ct2/show/NCT02090075
Ah, and look who is involved with both! Matthew Budoff, who seems to know more about CAC than anyone else. Good man.
again, a statement of research ... it will be interesting to see what they uncover.